In the current study, we found that FA relived hepatic fibrosis by, at least partly, directly binding to and acting as a PTP1B antagonist, which further confirmed our hypothesis that the binding ability between FA and AMPK was weaker than that between FA with PTP1B (Figure 5). Here, PRKAA1 is linked to Hepatic fibrosis.